GE Healthcare unveils Venue Fit™, a streamlined and compact POCUS system, alongside an industry-first AI offering for cardiac imaging on the Venue™ and Venue Go™.
Serena Bright is the industry’s first contrast-enhanced guided biopsy solution and will help empower clinicians and patients in their fight against breast cancer.
Methodical assessments of heart function are key in echocardiography but can be tedious and time-consuming to acquire. High-quality data acquisition and operator skill are key elements to achieve accurate and complete exams.
GE Healthcare to Distribute Osprey Medical’s Technology to Address Angiography Based Acute Kidney Injury
Under the four-year agreement, GE Healthcare will commercialize Osprey’s DyeVert portfolio which reduces the amount of contrast that reaches the kidney (40% average reduction) with no compromise in image quality.
GE Healthcare Receives FDA Clearance of the Industry’s First Contrast-Enhanced Mammography Solution for Biopsy
The clearance comes at a time when women’s health clinics worldwide begin to reopen and are managing new protocols to help reduce staff and patient exposure to COVID-19.